Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 806

1.

Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.

Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP; ELITE Research Group.

N Engl J Med. 2016 Mar 31;374(13):1221-31. doi: 10.1056/NEJMoa1505241.

PMID:
27028912
2.

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.

Chlebowski RT, Anderson GL, Aragaki AK, Prentice R.

J Natl Cancer Inst. 2015 Nov 5;108(2). pii: djv327. doi: 10.1093/jnci/djv327. Print 2016 Feb. Review.

PMID:
26546117
3.

Do Solid Pseudopapillary Neoplasms Shrink After Menopause?: Review of the Literature.

Kurokawa S, Hirabayashi K, Hadano A, Yamada M, Tajiri T, Nakamura N.

Pancreas. 2015 Aug;44(6):998-9. doi: 10.1097/MPA.0000000000000358. Review. No abstract available.

PMID:
26166473
4.

Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.

Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black DM, Budoff MJ, Hodis HN, Naftolin F, Harman SM, Asthana S.

PLoS Med. 2015 Jun 2;12(6):e1001833; discussion e1001833. doi: 10.1371/journal.pmed.1001833. eCollection 2015 Jun.

5.

Distinct cognitive effects of estrogen and progesterone in menopausal women.

Berent-Spillson A, Briceno E, Pinsky A, Simmen A, Persad CC, Zubieta JK, Smith YR.

Psychoneuroendocrinology. 2015 Sep;59:25-36. doi: 10.1016/j.psyneuen.2015.04.020. Epub 2015 May 14.

PMID:
26010861
6.

Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer.

Chlebowski RT, Anderson GL, Prentice RL, Rossouw JE, Aragaki AK, Manson JE.

Climacteric. 2015 Jun;18(3):336-8. doi: 10.3109/13697137.2015.1038770.

PMID:
25966858
7.

[Hormone replacement therapy and venous thromboembolism].

Pavičić Baldani D, Skrgatić L, Simunić V, Elvedi Gasparović V, Geršak B.

Lijec Vjesn. 2015 Jan-Feb;137(1-2):34-40. Croatian.

PMID:
25906547
8.

Ultrasonographic observation of the breast in early postmenopausal women during therapy with Cimicifuga foetida extract and sequential therapy with estrogen and progestin.

Gaowa S, Sun AJ, Jiang Y, He FW, Zheng TP, Wang YP.

Chin Med J (Engl). 2015 Apr 20;128(8):1000-4. doi: 10.4103/0366-6999.155052.

9.

17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review.

Mirkin S, Amadio JM, Bernick BA, Pickar JH, Archer DF.

Maturitas. 2015 May;81(1):28-35. doi: 10.1016/j.maturitas.2015.02.266. Epub 2015 Mar 9.

10.

Practice observed.

Gray S.

Post Reprod Health. 2015 Mar;21(1):37-9. doi: 10.1177/2053369115576632. No abstract available.

PMID:
25802143
11.

What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?

Lakryc EM, Machado RB, Soares Jr JM, Fernandes CE 3rd, Baracat EC.

Clinics (Sao Paulo). 2015 Feb;70(2):107-13. doi: 10.6061/clinics/2015(02)07. Erratum in: Clinics (Sao Paulo). 2015 Mar;70(3):228.

12.

Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.

Paoletti AM, Cagnacci A, Di Carlo C, Orrù MM, Neri M, D'Alterio MN, Melis GB.

Gynecol Endocrinol. 2015 May;31(5):384-7. doi: 10.3109/09513590.2014.1003294. Epub 2015 Feb 23.

PMID:
25703254
13.

Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical?

Shapiro S.

Climacteric. 2015 Jun;18(3):333-5. doi: 10.3109/13697137.2015.1007623. Epub 2015 Feb 5. No abstract available.

PMID:
25651904
14.

Is postmenopausal hormone replacement therapy suitable after a cardio- or cerebrovascular event?

Windler E, Stute P, Ortmann O, Mueck AO.

Arch Gynecol Obstet. 2015 Jan;291(1):213-7. doi: 10.1007/s00404-014-3485-0. Epub 2014 Oct 17.

PMID:
25322975
15.

Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study.

Sweeney EE, Fan P, Jordan VC.

Cancer Res. 2014 Dec 1;74(23):7060-8. doi: 10.1158/0008-5472.CAN-14-1784. Epub 2014 Oct 10.

16.

Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women.

Unfer TC, Figueiredo CG, Zanchi MM, Maurer LH, Kemerich DM, Duarte MM, Konopka CK, Emanuelli T.

Climacteric. 2015 Jun;18(3):379-88. doi: 10.3109/13697137.2014.964669. Epub 2014 Nov 12.

PMID:
25236970
17.

Hormones and venous thromboembolism among postmenopausal women.

Scarabin PY.

Climacteric. 2014 Dec;17 Suppl 2:34-7. doi: 10.3109/13697137.2014.956717. Epub 2014 Sep 16. Review.

PMID:
25223916
18.

Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic.

Posadzy-Malaczynska A, Rajpold K, Woznicka-Leskiewicz L, Marcinkowska J.

Clin Res Cardiol. 2015 Jan;104(1):38-50. doi: 10.1007/s00392-014-0755-6. Epub 2014 Sep 13.

19.

Body mass index, lipid metabolism and estrogens: their impact on coronary heart disease.

Kolovou GD, Kolovou V, Kostakou PM, Mavrogeni S.

Curr Med Chem. 2014;21(30):3455-65. Review.

PMID:
25174916
20.

Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study.

Clague J, Reynolds P, Henderson KD, Sullivan-Halley J, Ma H, Lacey JV Jr, Chang S, Delclos GL, Du XL, Forman MR, Bernstein L.

PLoS One. 2014 Jul 31;9(7):e103735. doi: 10.1371/journal.pone.0103735. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk